Team:Freiburg/Labjournals/irif/September
""
Home
Project
Team
Results
Human Practice
Notebook
Introduction
Overview
Diagnostics today
The DiaCHIP
DNA Engineering
Cell-Free Expression
Protein Purification
Surface Chemistry
Optical Detection
Outlook
Members
Acknowledgements
Partners
The DiaCHIP
Main Results
Diagnostics
Our Device
DNA Array
Cell-Free Expression
Binding on Surface
Modeling
BioBricks
Collaborations
Interlab Study
Achievements
Science Fair
Theater Project
Public Opinion
College Talk
Ethics
Labjournals
Techniques
Gibson
E.coli Strains
Protocols
Materials
Safety
Wiki-Tricks
Glossary
Home
Project
Results
Team
Practice
Notebook
Menu
<< Back
Labjournal iRIf September
Measuring own blood (tetanus vaccination)
16.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
pos. control (GFP)
0.5 mg/ml
5
BSA
5 mg/ml
6
Tetanus Antigen
~0.5 mg/ml
7
pos. control (GFP)
0.5 mg/ml
8
Tetanus Antigen
~0.5 mg/ml
17.09.2015 (measured)
Tet serum (-+): 024, 466
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
Serum(-)
4
30
900
1:10
Buffer
5
60
300
1x
anti GFP
6
30
900
1.5 µg/ml
Buffer
7
60
300
1x
Serum(-)
8
30
900
1:10
Buffer
9
60
300
1x
Tet serum (+-): 208, 216
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
Serum(-)
4
30
900
1:10
Buffer
5
60
300
1x
anti GFP
6
30
900
1.5 µg/ml
Buffer
7
60
300
1x
Serum(+)
8
30
900
1:10
Buffer
9
60
300
1x
GFP; Tet serum (-+): 287
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti GFP
4
30
900
1.5 µg/ml
Buffer
5
60
300
1x
Serum(-)
6
30
900
1:10
Buffer
7
60
300
1x
Serum(+)
8
30
900
1:10
Buffer
9
60
300
1x
Results
Serum(-),anti GFP,Serum(+):
Slide 024: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(-),anti GFP, serum(+)
Slide 024: binding curves
]
Slide 466: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(-),anti GFP, serum(+)
Slide 466: binding curves
Serum(+),anti GFP,Serum(-):
Slide 208: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(+),anti GFP, serum(-)
Slide 208: binding curves
Slide 216: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(+),anti GFP, serum(-)
Slide 216: binding curves
anti GFP,Serum(-),Serum(+):
Slide 287: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: anti GFP, serum(-), serum(+)
Slide 287: binding curves
Measuring : The **DIA Chip**
14.09.2015 (stamped)
PDMS Dia-Chip stamp (incubated 30 minutes with 1 mg/ml GFP) was stamped onto plasmaactivated slide. Kept in 10 mg/ml BSA in PBS at 4° until measurement.
16.09.2015 (measured)
Slides were previously blocked with the backside of a PDMS flowcell to avoid airbubble issues due to the hydrophobicity of the stamp.
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
5 ug/ml
Buffer
5
60
300
1x
StrepCy5
6
60
300
5 ug/ml
Buffer
9
60
300
1x
Slide 287: Cy5 signal after iRIf measurement detected in microarray scanner
Slide 303: Quotient picture of the anti-GFP step
Rabbit-serum (GFP immunized/not immunized) on PDITC
14.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (bBSA)
0.2 mg/ml
2
neg. control (BSA)
0.2 mg/ml
3
His-GFP desalt
1mg/ml
4
pos. control (bBSA)
0.2 mg/ml
5
neg. control (BSA)
0.2 mg/ml
6
His-GFP desalt
1mg/ml
7
His-mCherry desalt
1 mg/ml
8
His-mCherry desalt
1 mg/ml
15.09.2015 (measured)
Flush protocol: Positive serum (504,424,466).  Negative serum (423).
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
StrepCy5
4
30
600
5 ug/ml
Buffer
5
60
300
1x
Serum (+)/(-)
8
30
900
1:30
Buffer
9
60
600
1x
Anti-Rabbit
10
60
300
5 ug/ml
Buffer
11
60
300
1x
*Slide 466 was measured with 10 ug/ml Anti-Rabbit
Results: Serum (-) fromm rabbit that was not immunized to GFP shows no binding to the GFP spot.
Serum (+) from rabbit that was immunized to GFP shows extensive binding to the GFP spot.
Slide 423 (serum(-)): Selections of ROIs
Slide 423 (serum(-)): Binding curves
Slide 424 (serum(+)): Selection of ROIs
Slide 424 (serum(+)): Binding curves
Slide 466 (serum(+)): Selections of ROIs
Measuring own blood (Tetanus vaccination)
13.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
14.09.2015 (measured)
Tet serum (-): 208, 254
Tet serum (+): 500, 024
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
900
1:20
Buffer
7
60
300
1x
Anti Human
8
30
600
5 ug/ml
Buffer
9
60
300
1x
StrepCy5
10
30
600
5 ug/ml
Buffer
11
60
300
1x
Results
Blood Serum(-):
Slide 208: Quotion picture, flushed with 1:20 diluted blood serum (-)
Slide 208: binding curves
]
Slide 254: Quotion picture, flushed with 1:20 diluted blood serum (-)
Slide 254: binding curves
Blood serum(+):
Slide 024: Quotion picture, flushed with 1:20 diluted blood serum (+)
Slide 024: binding curves
Slide 500: Quotion picture, flushed with 1:20 diluted blood serum (+)
Slide 500: binding curves
Measuring own blood serum (Tetanus vaccination)
12.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
13.09.2015 (measured)
Tet serum (-): 443, 466
Tet serum (+): 423, 424
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
900
1:10
Buffer
7
60
300
1x
Anti Human
8
30
600
5 ug/ml
Buffer
9
60
300
1x
StrepCy5
10
30
600
5 ug/ml
Buffer
11
60
300
1x
Results
Blood Serum(-):
Slide 443: Quotion picture, flushed with 1:10 diluted blood serum (-)
Slide 443: binding curves
]
Slide 466: Quotion picture, flushed with 1:10 diluted blood serum (-)
Slide 466: binding curves
Blood serum(+):
Slide 423: Quotion picture, flushed with 1:10 diluted blood serum (+)
Slide 423: binding curves
Slide 424: Quotion picture, flushed with 1:10 diluted blood serum (+)
Slide 424: binding curves
Measuring own blood (Tetanus vaccination)
05.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
06.09.2015 (measured)
Flush protocol:
Tet serum (-): 443
Tet serum (+): 466
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
600
1:4
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Tet serum (-): 208
Tet serum (+): 303
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
60
600
1:6
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Note: the amount of flushed serum
Results
Blood Serum(-):
Slide 208: Quotion picture, flushed with 1:6 diluted blood serum (-)
Slide 208: binding curves
Slide 443: Quotion picture, flushed with 1:4 diluted blood serum (-)
Slide 443: binding curves
Blood serum(+):
Slide 303: Quotion picture, flushed with 1:6 diluted blood serum (+)
Slide 303: binding curves
Slide 466: Quotion picture, flushed with 1:4 diluted blood serum (+)
Slide 466: binding curves
→ for the blood serum after immunization (+) the iRIf signal for tetanus binding is higher than for the blood serum before immunization (-)
→ there are differences to the results of experiment 59a, the overall tetanus signal is much weaker as well as the binding of the blood serum to bBSA
Measuring own blood: Tetanus (-), Tetanus (+)
04.09.15 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
Flush protocol:
SIG 003 (+): 012(no serum was flushed over the slide), 315, 426
SIG 002 (+): 215
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Blood serum
6
30
600
1:10/1:30
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Results
SIG 003:
Slide 012: Quotion picture
Slide 012: binding curves
Slide 315: Quotion picture
Slide 426: Quotion picture
Slide 426: binding curves
→ slide 012 was not flushed with any blood serum → for blood serum SIG 003 only a slight antigen/antibody binding is detectable (slide 426)
SIG 002:
Slide 215: Quotion picture
Slide 215: binding curves
→ slight antigen/antibody binding is detectable
→ no anti GFP/ GFP binding detected
→ only weak binding of the blood serum to bBSA → difference to results of experiment 59a
Specific surface (Ni-NTA) vs. unspecific surface (PDITC): cellfree expressed GFP
04.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
cell free expression mix without DNA (KK)
3
cell free expressed HA-GFP-His6-His6 (KK)
4
pos. control (GFP)
0.5 mg/ml
5
cell free expression mix without DNA (KK)
6
cell free expressed His10-GFP-Spy (KK)
7
BSA
5 mg/ml
8
bBSA
200 µg/ml
05.09.2015 (measured)
Flush protocol:
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
PDITC:
Slide 216: Quotion picture
Slide 216: binding curves
Slide 254: Quotion picture
Slide 254: binding curves
Ni-NTA:
Slide 102: Quotion picture
Slide 102: binding curves
Slide 502: Quotion picture
Slide 502: binding curves
→ the his tagged, cell free GFP was specificly bound by the Ni NTA surface, whereas there was no detectable amount of cell free GFP bound on the PDITC surfaces
→ the PDITC surface binds all proteins in the spotted cell free expression mix eaqually good, whereas the Ni-NTA surface specificly binds only the his tagged, cell free expressed GFP
Measuring own blood: Tetanus (-), Tetanus (+) Sig002
02.09.2015 (spotted) Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
mCherry
0.5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
BSA
10 mg/ml
5
BSA(+bBSA)
10 mg/ml
6
bBSA
200 µg/ml
03.09.2015 (measured)
Tet (-): 287,429 (1:30 diluted serum) Tet (+): 443, 423 (1:30 diluted serum)
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
20
900
1:10
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Slide 287: ROI selection, ROIs were chosen in similar manner for the other slides
Slide 287: Binding curves; serum (-) diluted 1:10
Slide 443: Binding curves; serum (+) diluted 1:10
Slide 429: Binding curves; serum (-) diluted 1:30
Slide 423: Binding curves, serum (+) diluted 1:30
Distinguish between different antigen/antibody interaction (Salmonella) (on PDITC) [finished]
01.09.2015 (spotted)
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
bBSA
0.5 mg/ml
3
Salmonella Antigen (15)
undiluted
Slides (3): 208,215,216 last slide (208) changed protocol: only 1 ug/ml anti-GFP used; anti-Salmonella desalt was mixed 1:1 with anti-Salmonella lysate
02.09.2015 (measured)
Flush protocol:
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer (TBS)
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer (TBS)
3
60
600
1x
anti-GFP
4
30
600
1,5 ug/ml
Buffer (TBS)
5
60
300
1x
anti-Salmonella (13, desalt)
6
30
900
undiluted
Buffer (TBS)
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer (TBS)
9
60
300
1x
Note: Background of Slides 208 looked nicest.
Slide 208: ROI selection
Slide 208: Binding curves
Slide 215: Binding curves
Slide 216: Binding curves
